Inventor
Peter Buhl Jensen
Inventor
Farum, DK
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data10%
PatentTitleYear
10,835,531Methods for predicting drug responsiveness in cancer patients20207,906,515'Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation'20116,727,253'Treatment of accidental extravasation of anthracyclines'20046,265,385'Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001Patents assigned to TOPO TARGET APS (1)· patent assignee history
2001–2020Based in Farum, DK· patent location history
2004Patents assigned to ANTIANTHRA APS (1)· patent assignee history
2011Patents assigned to TOPOTARGET AS (1)· patent assignee history
2011Based in Copenhagen, DK· patent location history
2020Patents assigned to Oncology Venture ApS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ANTIANTHRA APS | 1 | 2004 |
| Oncology Venture ApS | 1 | 2020 |
| TOPO TARGET APS | 1 | 2001 |
| TOPOTARGET AS | 1 | 2011 |
Locations
| Location | Patents | Span |
|---|---|---|
| Farum, DK | 3 | 2001–2020 |
| Copenhagen, DK | 1 | 2011 |